Mereo BioPharma (MREO) Shares Issued (2021 - 2026)

Mereo BioPharma (MREO) has reported Shares Issued for 6 consecutive years, with $19.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Issued rose 46.21% year-over-year to $19.9 million; the TTM figure through Mar 2026 stood at $19.9 million (up 46.21% YoY), while the FY2025 annual figure was $13.5 million, up 19.58% from the prior year.
• Shares Issued climbed to $19.9 million in Q1 2026 per MREO's latest filing, from $13.5 million in the prior quarter.
• Across five years, Shares Issued topped out at $19.9 million in Q1 2026 and bottomed at $8.0 million in Q4 2022.
• Historically, Shares Issued has averaged $12.5 million across 5 years, with a median of $11.9 million in 2024.
• Annual changes were most pronounced in 2022 — Shares Issued surged 51.31% — and 2025, when it increased 14.79%.
• Mereo BioPharma's Shares Issued stood at $8.0 million in 2022, then climbed by 19.29% to $9.6 million in 2023, then advanced by 17.47% to $11.3 million in 2024, then grew by 19.58% to $13.5 million in 2025, then jumped by 47.56% to $19.9 million in 2026.
• Business Quant data shows MREO's Shares Issued at $19.9 million in Q1 2026, $13.5 million in Q4 2025, and $13.5 million in Q3 2025.